Article June 15, 1997

Cognitive-Behavioral Management of Drug-Resistant Major Depressive Disorder

; ; ;

J Clin Psychiatry 1997;58(6):278-282

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders


Article Abstract

Background: The application of cognitive-behavioral treatment to drug-resistant major depression has received little research attention.

Method: Nineteen patients who failed to respond to at least two trials of antidepressant drugs of adequate dosages and duration were treated by cognitive-behavioral methods in an open trial.

Results: Three patients dropped out of treatment. The remaining 16 patients displayed a significant (p

Conclusion: These preliminary results suggest that a trial of cognitive-behavioral therapy by an experienced therapist should be performed before labeling an episode of major depression as “refractory” or “treatment resistant.” These latter terms should apply only when a psychotherapeutic effort has been made. Until then, it seems more appropriate to define depression as “drug refractory” or “drug treatment resistant.”

Members Only Content

This full article is available exclusively to Professional tier members. Subscribe now to unlock the HTML version and gain unlimited access to our entire library plus all PDFs. If you’re already a subscriber, please log in below to continue reading.

Subscribe Now

Already a member? Log in

CME LogoCME Logo

View Related Activity

Go to Activity